Submitted by ACMES
The American Chinese Medical Exchange Society spring conference took place on April 7 at Harvard Medical School’s Dana Farber Cancer research center’s auditorium. Eight expert speakers presented to more than 100 local doctors and medical researchers day. Liu Zhao, Medical Director of ACMES gave the opening speech, while Kong Xuejun, ACMES President closed the conference. Other doctors included Lin Xu, Zhou Renshi, Wang Hao, Zhan Hui, Liu Shubo and Lu Ping.
Peter Kang, associate professor at Harvard Medical School and cardiovascular director at Beth Israel Deaconess Medical Center, discussed existing and emerging treatment of cardiovascular disease. Kang showed that the life expectancy for Chinese people went from 33 years in 1960 to 72 in 2000, or an increase of 39 year. For the United States, life expectancy went from 68 years in 1960 to 76 in 2000. Cardiovascular disease is the No. 1 killer of Americans, but just the third cause of death among the Chinese. Heart failure treatments have evolved, including genome analysis, stem cells and nanotechnology.
Margo Hudson of Brigham and Women’s Hospital discussed type two diabetes and insulin therapy, and when to start and how to continue and when the end of insulin therapy. Another former colleague of Hudson was Jiang Keyi, who is now a pediatrician at Harvard Vanguard physician, MD. As the mother of two daughters, she understands infant and childhood nutrition, using photos of her daughters during her presentation.
The management and treatment of chronic pain was presented by Edison Wong, director of medical education at HealthAlliance Hospital. Wong explained that in order to manage risk, it is necessary to correctly assess of the level of risk. After explain the different levels of risk , he gave three case studies for the audience to “diagnose,” prompting good audience interaction.
Treatment of severe sepsis and septic shock was presented by Liu Peichang, intensive care physician at Beth Israel Deaconess Medical Center. From his experience, Liu recommended assuming that every patient in shock is in septic shock, so all preventive measures can be taken.
Next-generation gene sequencing was discussed by Wu Bolin, assistant professor at Harvard Medical School and genetic laboratory director at Boston Children’s Hospital. Wu joked that $1,000 gene sequencing today is able to decode the genome, which was first completed at a cost of $1 million. He predicted that by 2050, the scientific community will be able to see a truly personalized genome map.
Chinese medicine was part of the conference. Hu Kaiwen, Beijing University of Chinese Medicine’s oncology department look at cancer treatment from a traditional Chinese point of view. Western medicine is more aggressive with surgery to dig out tumors, along with the patient’s surrounding tissue, making it unsuited for older and weak patients. Chinese medicine pays attention to “palliative” treatment. The difference is operating on the core of a tumor but leaving small isolated tumors alone for observation. Typically, once the worst of the tumor is remove, the body heals other smaller areas, Hu said. He also discussed newer surgical techniques that were minimally invasive. His comprehensive therapy proved successful for patients, who had less pain, faster healing and prolonged life. Audience members had a lively discussion and questions about Hu’s research.
Liu Yuanli of the Harvard School of Public Health and China program director discussed Chinese medical professionalism. In a survey of Chinese hospital presidents, 42 percent felt that the level of knowledge for medical students was dropping. The survey also found that the 70 percent of perceived worse clinical skills among medical school graduates and 54 percent saw worsening work attitudes. From their perspective, only 40 percent put their patients first; 60 percent felt Chinese doctors made money and prestige their priority. This has increased tension and mistrust between doctors and patients. In addition, 72 percent of the presidents do not want their children to study medicine. Liu believes health care reform is in order. The requirements for medical professionals and their rewards are not aligned. He felt it was unrealistic to expect doctors to perform at their best for nothing is unrealistic, which requires changes for doctors and society.
The conference started and ended with liver disease presentations from experts. Raymond Chung, liver transplant director and deputy director of gastroenterology at Massachusetts General Hospital, discussed the latest developments hepatic encephalopathy. Hepatic encephalopathy is one of the major complications of cirrhosis, with the lowest survival rate for liver disease patients. He stressed that preventive treatment is crucial and gave specific steps for how to do so.
The final lecture focused on hepatitis C, presented by Liu Danyang, Harvard Medical School associate professor and Cancer Center director for Beth Israel Deaconess Medical Center. Participants were able to earn continuing education credits from Liu’s lecture. Different types of hepatitis affect certain groups differently. Hepatitis B is prevalent among Asians, while hepatitis C is more common about Hispanics and Caucasians. Liu talked about anti-hepatitis C virus and how to treat patients long term.
For more information, please visit www.acmes.net.
This post is also available in: Chinese